Biogen Stemceuticals, Inc. – Trademark Portfolio
Entity Type: 03
Biogen Stemceuticals, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include JUAGE and JUVIQA. The owner is based in Frisco, TX.
Suite 300
2591 Dallas Parkway
Frisco, TX 75034
Showing of trademarks Trademarks
Trademark Classifications
Biogen Stemceuticals, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Biogen Stemceuticals, Inc. have?
Biogen Stemceuticals, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.
What trademark classes does Biogen Stemceuticals, Inc. file in?
Biogen Stemceuticals, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Biogen Stemceuticals, Inc.'s most well-known trademarks?
Biogen Stemceuticals, Inc.'s registered trademark portfolio includes well-known marks such as JUAGE and JUVIQA. These are among 2 currently registered trademarks in the portfolio.
What is Biogen Stemceuticals, Inc.'s trademark registration success rate?
Biogen Stemceuticals, Inc. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.